US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10 (about Rs 730) a dose in India, sources close to the development indicated.
This could be the lowest price of the vaccine globally, and almost half the price in developed markets like the US, UK, and EU.
“It is a single-digit price per dose,” a source said.
“This is a not-for-profit price for the government’s immunisation programme.” Pfizer is now in discussions with the Indian government for supplying the vaccine.
The drug manufacturer said its priority would be to exclusively support governments by supplying its vaccine only to governments for their immunisation programmes.
